The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Group 2 Innate Lymphoid Cells in Airway Diseases
Open accessAbstract
Group 2 innate lymphoid cells (ILC2s) are increasingly recognized as a key controller of type 2 inflammation, and are well known to be highly elevated in human airway type 2 inflammatory diseases including allergic rhinitis, chronic rhinosinusitis with nasal polyps, and asthma. ILC2-mediated production of type 2 cytokines initiates and amplifies airway inflammation via activation of eosinophils, B cells, mast cells, macrophages, fibroblasts, and epithelial cells in these diseases. ILC2s require at least three major signals to fully activate and robustly produce type 2 cytokines. IL-1 family cytokines (IL-1β, IL-18, IL-33), IL-25, and TNF superfamilies (TNF, TL1A, GITR-L, RANK-L) activate the NF-κB and AP-1 pathways that initiate production of IL-5 and IL-13. Lipid mediators (LTC4, LTD4, PGD2) and neuropeptide NMU promote production of IL-4 through the NFAT pathway. IL-2 and IL-7 family cytokines (IL-2, IL-7, IL-9, TSLP) activate the STAT5 pathway that induces survival of ILC2s and enhances cytokine production. The activation of STAT5 is necessary to potently induce cytokine- and lipid mediator-mediated production of type 2 cytokines. Inhibitory pathways for ILC2s have also become clearer. Type I and II interferons and IL-27 inhibit ILC2 functions through the activation of STAT1. Suppression mediated via β2-adrenergic receptor agonists, PGE2, and PGI2 occurs through cAMP and PKA. Glucocorticoid, testosterone, IL-10, and TGF-β are also able to inhibit ILC2-mediated production of type 2 cytokines. Blockage of ILC2 activators, activation of inhibitory pathways of ILC2s, and suppression of ILC2-mediated pathways including type 2 cytokines (IL-5, IL-13, IL-4Ra) may become therapeutic strategies for airway type 2 inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit
von Moltke, J., Ji, M., Liang, H.-E., & Locksley, R. M. (2016) · Nature · doi:10.1038/nature16161 · Cited by 1,230
Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166
Neuronal regulation of type 2 innate lymphoid cells via neuromedin U
Cardoso, V., Chesné, J., Ribeiro, H., García-Cassani, B., Carvalho, T., Bouchery, T., Shah, K., Barbosa-Morais, N. L., Harris, N., & Veiga-Fernandes, H. (2017) · Nature · doi:10.1038/nature23469 · Cited by 592
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557 · cited 2×
“During IgE-mediated reactions, mast cells quickly release lipid mediators including LTs and PGD2 that are elevated in the nasal mucosa of patients with allergic rhinitis.(43,45,48) These lipid mediators may play an initial”
BackgroundEnhanced innate type 2 immune response in peripheral blood from patients with asthma
Bartemes, K. R., Kephart, G. M., Fox, S. J., & Kita, H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.024 · Cited by 390 · cited 1×
“Many groups have clearly shown that ILC2s are increased in blood and sputum in patients with asthma, especially in type 2 high severe eosinophilic asthma.(27,58-60) Smith et al(59) also found that IL-5þIL-13þ”
BackgroundMorita, H., Arae, K., Unno, H., Miyauchi, K., Toyama, S., Nambu, A., Oboki, K., Ohno, T., Motomura, K., Matsuda, A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.021 · Cited by 274
Lao-Araya, M., Steveling, E., Scadding, G. W., Durham, S. R., & Shamji, M. H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.029 · Cited by 200 · cited 2×
“However, patients with seasonal allergic rhinitis who received allergenspecific immunotherapy did not show seasonal elevation of blood ILC2s.(46) These results indicate that ILC2s are elevated locally and systemically in patients with allergic rhinitis and that the accumulation of ILC2s is controlled at least in part…”
BackgroundKohanski, M. A., Workman, A. D., Patel, N. N., Hung, L.-Y., Shtraks, J. P., Chen, B., Blasetti, M., Doghramji, L., Kennedy, D. W., Adappa, N. D., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.019 · Cited by 159
Prostaglandin E2 suppresses human group 2 innate lymphoid cell function
Maric, J., Ravindran, A., Mazzurana, L., Björklund, Å. K., Van Acker, A., Rao, A., Friberg, D., Dahlén, S.-E., Heinemann, A., Konya, V., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.09.050 · Cited by 140
Doherty, T. A., Scott, D., Walford, H. H., Khorram, N., Lund, S., Baum, R., Chang, J., Rosenthal, P., Beppu, A., Miller, M., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1086 · Cited by 119 · cited 1×
“ILC2s in peripheral blood and nasal curettage samples are increased after nasal allergen challenge in patients with allergic rhinitis, and ILC2 numbers in these nasal curettage samples positively correlate with eosinophil numbers and IL-5 concentrations.(44,45) Peripheral blood ILC2s are increased during pollen season…”
Background
Cited by
Type 2 inflammation in asthma and other airway diseases
Maspero, J., Adir, Y., Al-Ahmad, M., Celis-Preciado, C. A., Colodenco, F. D., Giavina-Bianchi, P., Lababidi, H., Ledanois, O., Mahoub, B., Perng, D.-W., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00576-2021 · Cited by 315
Mechanisms and pathogenesis of chronic rhinosinusitis
Kato, A., Schleimer, R. P., & Bleier, B. S. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.016 · Cited by 306
Self-citation
Metadata
- Authors
- Kato, A.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 156
- Issue
- 1
- Pages
- 141-149
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2943909458
- Cited by
- 194
- References
- 10
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.